International Networks of Excellence Program in Acute Rheumatic Fever Biomarker Project
|סוג||Research Grants, Partnership Activities|
|פקולטה||Engineering, Exact Sciences, Life Sciences, Medicine|
Acute rheumatic fever initiates a slow but progressive process of heart valve damage termed rheumatic heart disease. The challenge for the applicants is to identify a biomarker(s) for acute rheumatic fever that can serve as a basis for a test or panel of tests to accurately distinguish patients with acute rheumatic fever from individuals who do not have acute rheumatic fever.
*Network members must be from at least two continents*
**Multidisciplinary teams are a must**
It is expected that one (1) award will be granted.
Funding: $8,000,000 total
Duration: 5 years
Research Authority due date: 13.1.22
LOI (required) due date: 21.1.22
Full application due date: May 2022
|עדכון אחרון||עדכון אחרון: 24/10/2021|